Form 4: Bausch Health Director Amy Wechsler Reports Acquisition of Common Shares

Director Amy Wechsler reported acquiring 647 common shares of Bausch Health Companies Inc. at a price of $10.61 on March 29, 2024.

Summary

• On March 29, 2024, Amy Wechsler, a director of Bausch Health Companies Inc., acquired 647 common shares at $10.61 per share.
• Following the transaction, Wechsler's direct ownership amounts to 169,906 common shares.
• The transaction involved the acquisition of restricted share units, each representing a contingent right to receive one common share of Bausch Health Companies Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's share acquisition. While insider buying can be seen as positive, it's a relatively small transaction.

Positives

• The director's acquisition of shares could be interpreted as a positive signal regarding their confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

• The transaction provides shareholders with information about insider trading activity.

Key Dates